RT Journal Article
SR Electronic
T1 Correction: <em>Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002568corr1
DO 10.1136/jitc-2021-002568corr1
VO 9
IS 8
YR 2021
UL http://jitc.bmj.com/content/9/8/e002568corr1.abstract